RADNOR, Pa.--(BUSINESS WIRE)--PolyMedix, Inc. (OTC BB: PYMX, www.polymedix.com), an emerging biotechnology company developing acute care products for infectious diseases and acute cardiovascular disorders, will be presenting at the Healthtech Drug Development Conference: The Challenge of Antibacterial Drug Development. The presentation will be given by PolyMedix Vice President of Clinical Development & Chief Medical Officer, Dr. Eric McAllister, on Wednesday, March 18, 2009, at 5:35 pm.
